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Abstract
Maladaptive, Th2-polarized inflammatory responses are integral to the pathogenesis of allergic asthma. As regulators of T
cell activation, dendritic cells (DCs) are important mediators of allergic asthma, yet the precise signals which render
endogenous DCs ‘‘pro-asthmatic’’, and the extent to which these signals are regulated by the pulmonary environment and
host genetics, remains unclear. Comparative phenotypic and functional analysis of pulmonary DC populations in mice
susceptible (A/J), or resistant (C3H) to experimental asthma, revealed that susceptibility to airway hyperresponsiveness is
associated with preferential myeloid DC (mDC) allergen uptake, and production of Th17-skewing cytokines (IL-6, IL-23),
whereas resistance is associated with increased allergen uptake by plasmacytoid DCs. Surprisingly, adoptive transfer of
syngeneic HDM-pulsed bone marrow derived mDCs (BMDCs) to the lungs of C3H mice markedly enhanced lung IL-17A
production, and rendered them susceptible to allergen-driven airway hyperresponsiveness. Characterization of these
BMDCs revealed levels of antigen uptake, and Th17 promoting cytokine production similar to that observed in pulmonary
mDCs from susceptible A/J mice. Collectively these data demonstrate that the lung environment present in asthma-resistant
mice promotes robust pDC allergen uptake, activation, and limits Th17-skewing cytokine production responsible for driving
pathologic T cell responses central to the development of allergen-induced airway hyperresponsiveness.
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Introduction
Allergic asthma, a disease that continues to rise in both
incidence and morbidity in the developed world, manifests as
recurrent episodes of wheezing, shortness of breath and coughing
in response to environmental stimuli. Although the origins of
asthma are complex, it is accepted that asthma results from an
inappropriate, Th2-dominated immune response to environmen-
tal allergens in genetically predisposed individuals. In asthmatic
individuals, allergen exposure facilitates expansion of pathogenic,
allergen-specific Th2 cells producing IL-4, IL-5 and IL-13,
cytokines which induce pulmonary eosinophilic inflammation,
IgE synthesis, airway wall remodeling and airway hyperrespon-
siveness (AHR), hallmarks of allergic asthma [1]. In contrast, non-
asthmatic individuals respond in a fundamentally different way,
becoming tolerized through the activation of immunosuppressive
CD4+CD25+ regulatory T cells secreting IL-10 and TGFb [2,3].
However, despite an increasingly sophisticated understanding of
the pathogenesis of allergic asthma, the factors that promote the
initial development of a pathogenic versus protective T cell
response remain unknown.
As professional antigen presenting cells, dendritic cells (DCs) are
capable of skewing T cell differentiation towards a pathogenic or
regulatory phenotype through a number of mechanisms. For
example, the panel of co-stimulatory molecules expressed by DCs
plays a role in the type of T cell response elicited - CD86 and
OX40L contribute to the development of pathogenic Th2 cells,
[4–6] while ICOS-L and PD-1/PD-L promote the development of
protective regulatory T cells [7–11]. DCs also directly regulate T
cell differentiation by producing cytokines that drive the
differentiation/expansion of Th2 cells (IL-6 alone [12,13]), Th17
cells (IL-6+TGFb/IL-23 [12,14,15]), Tregs (TGFb/IL-10 [16–
18]) or Th1 cells (IL-12 [19]). Identification of a DC-produced
cytokine directly responsible for inducing the development of Th2
cells remains elusive, yet the Th2-skewing capacity of DCs can be
influenced by a number of factors [20–25]. Finally, the recent
identification of distinct DC subsets has provided another
mechanism through which DCs may control the development of
pathogenic or regulatory T cell responses. Myeloid DCs (mDCs),
are effective T cell stimulators, inducing a variety of effector T cell
responses (e.g. Th1, Th2 or Th17) dependent upon the types of
stimuli they receive, and the compartment from which they are
isolated [26–28]. In contrast, while plasmacytoid DCs (pDCs)
strongly induce the development of regulatory T cells as a result of
elevated PD-L1 expression [29–31], they can also induce the
development of IFNc-producing Th1 cells after viral exposure, or
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adapt to conditions present at the time of antigen encounter,
promoting responses appropriate to the specific antigen, a
response further fine-tuned by the types of DC subset involved
in antigen presentation.
Dendritic cells in the lung play an important role in the
development of allergic airway responses. In the large airways,
DCs form a network below the epithelial cell layer [34–36], a
position from which they sample and transport inhaled antigens
present in the airway lumen to lung-draining LNs, where T cell
activation occurs [37]. Airway DCs increase in numbers following
allergen challenge in both human, and animal models [38,39]
suggesting an important role for these cells in asthma. Indeed,
transfer of Ag-pulsed, bone marrow-derived mDCs to the airways of
naı ¨ve animals is sufficient to sensitize mice for subsequent
development of allergic asthma [40–43]. In contrast, adoptive
transfer of Ag-pulsed, bone marrow-derived pDCs induces tolerance
[29], elegantly demonstrating that in vitro derived DC subsets have
markedly differing capacities to induce pathogenic or protective T
cellresponses. However, in vivo, the precise subset of DCs responsible
for inducing pathogenic versus protective T cell responses, the
pattern of DC-derived cytokines that drive these T cell responses,
and the extent to which DC subset recruitment and cytokine
production are regulated by the pulmonary environment and
genetics in asthma-susceptible and resistant hosts, remains unclear.
To address these questions, we utilized a murine model of
susceptibility to allergen-induced airway hyperresponsiveness (AHR)
wherein intratracheal administration of house dust mite (HDM)
inducesthedevelopment of AHR insusceptibleA/J animals,but has
little impact on AHR in resistant C3H mice. Using this model, we
demonstrate that following allergen exposure in susceptible hosts,
allergen uptake is predominantly by pulmonary mDCs capable of
high level co-stimulatory molecule expression and the production of
Th17-promoting cytokines production (IL-6, IL-23), and that these
factors are critical for the development of allergen-induced airway
hyperresponsiveness. Moreover, transfer of mDCs with a susceptible
phenotype completely reconstitutes susceptibility in resistant hosts.
Taken together, our results suggest that factors in the pulmonary
environment regulate the activation of mDCs, controlling the
expression of high levels of co-stimulatory molecules, and Th17-
promoting cytokines (IL-6, IL-23) critical for the development of T-
cell dependent airway hyperresponsiveness.
Results
Development of HDM-based model of experimental
asthma
To test the hypothesis that differences in susceptibility to
allergen-driven AHR in A/J and C3H mice result from differential
regulation of pulmonary DC recruitment or activity, we developed
a model in which allergen sensitization occurs via the airways.
Specifically, we examined the impact of i.t. administration of
house dust mite extract (HDM), a natural aeroallergen, on
subsequent development of allergen-induced AHR. As shown in
Figure 1a, 24 hours after a second i.t. HDM exposure, AHR rose
in A/J animals, reaching a plateau 4–5 fold higher than baseline
by 72 hours. In contrast, in C3H mice, airway responses remained
indistinguishable from baseline at 24 hours, and were only
modestly increased (,2-fold) 72 hours after allergen exposure.
Interestingly, in spite of the well-documented role of IL-13 as a
central mediator of allergic asthma [44], production of Th2
cytokines (IL-4, IL-5, IL-13) was similar in HDM re-stimulated
lung cell cultures from A/J and C3H mice, while production of
IFNc was induced only in lung cell cultures from C3H mice
(Figure 1b). However, the levels of IFNc are quite low, indicating a
clear Th2 bias to immune response in both resistant and
susceptible animals and suggesting that resistance is not associated
with the preferential induction of a Th1 response in this model.
Interestingly, lung cell cultures from susceptible A/J mice
produced significantly greater amounts of IL-17A upon HDM-
restimulation, suggesting that concomitant induction of Th2 and
Th17 responses may be required for the manifestation of AHR in
allergen-sensitized hosts (Figure 1b). HDM exposure also induced
a similar degree of BAL eosinophilia (Figure 1c), and total and
HDM-specific IgE synthesis (Figure 1d) in A/J and C3H mice.
Interestingly, despite the elevated IL-17A production observed in
HDM-restimulated lung cell cultures from A/J mice, the degree of
BAL neutrophilia was indistinguishable in A/J and C3H mice
(Figure 1c). It is important to note that, while the C3H mice used
in these studies possess a mutation in TLR4 rendering them
resistant to LPS signaling, the inability to respond to LPS does not
seem to underlie their genetic resistance, as C3H mice which do
not possess the mutation in TLR4 (C3H/HeN) respond identically
to HDM (data not shown). Thus, to assess the importance of
endogenous DC subsets in controlling resistance or susceptibility in
a genetic model of asthma, we made use of the HDM-based model
of experimental asthma in subsequent studies.
Allergen uptake by pulmonary DC subsets in resistant
and susceptible mice
To assess whether genetic differences responsible for conferring
susceptibility to the development of allergen-induced AHR are
associated with changes in the balance of mDCs and pDCs taking
up allergen at the time of sensitization, A/J and C3H mice were
given a single i.t. dose of PBS or AlexaFluor 405 labeled-HDM
(AF405-HDM), sacrificed 24 or 72 hours later, and lung DC
subsets were quantified by flow cytometry. We classified 7-
AAD
negCD11b
+CD11c
+Gr1
neg cells as mDCs while pDCs were
classified as 7-AAD
negCD11b
negCD11c
+Gr1
+ (Figure S1). To
confirm that the cells we identified were, in fact, mDCs and pDCs,
we further analysed gated DC population for expression of B220,
and CD317, markers of pDCs [45,46]. While pDCs expressed
CD317 at the highest levels, as measured by surface staining with
mPDCA-1 and 120g8, neutrophils also expressed this marker
(Figure S1). Indeed, CD317 was recently found to be expressed
not only on pDCs, but also upregulated upon cells following
activation with type I or type II IFNs [46], suggesting that a
portion of neutrophils in the lung may be activated following
HDM exposure. In contrast, only pDCs expressed B220 to any
extent (Figure S1). Collectively, these data suggest that the 7-
AAD
negCD11b
negCD11c
+Gr1
+ in these studies are pDCs.
Gating on mDCs or pDCs from AF405-HDM-treated A/J and
C3H mice revealed that both mDCs and pDCs had taken up
allergen (Figure 2a). However, compared to C3H mice at similar
time points, in A/J mice, we observed a significantly greater
proportion of mDCs that contained allergen (Figure 2b). On a per
cell basis, HDM
+ mDCs from A/J mice also contained
significantly greater levels of allergen (as measured by AF405-
HDM MFI) compared to mDCs from C3H mice (Figure 2c). In
contrast, examination of pDCs revealed that at both 24 and
72 hours after allergen challenge, those from C3H mice were
more frequently positive for allergen (Figure 2b), and contained
more allergen per cell (Figure 2c), than those from A/J animals. As
a direct measure of the balance of immunogenic mDCs and
tolerogenic pDCs in the lung, we also determined the ratio of
HDM
+ mDCs to HDM
+ pDCs in the lung at various times after
challenge. As shown in Figure 2d, in both A/J and C3H mice, the
mDC:pDC ratio increased steadily over time after allergen
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PLoS ONE | www.plosone.org 2 December 2008 | Volume 3 | Issue 12 | e3879Figure 1. Intratracheal HDM exposure induces AHR and a mixed Th2/Th17 cytokine profile in A/J, but not C3H mice. A/J (solid bars) and
C3H (open bars) mice were sensitized and challenged with PBS or HDM as described in Materials and Methods. Mice were sacrificed 24 or 72 hours after
the second HDM/PBS exposure and AHR was assessed (A). Cytokine levels were determined in lung cell cultures stimulated with medium alone, or in the
presence of HDM (30 mg/ml) (B). Cellular composition of the BAL fluid was determined (C). Serum total and HDM-specific IgE levels were quantified (D).
Mean+SEMshown.N=12micefrom3independentexperiments.*and**indicatesignificantdifferencesofp,0.05andp,0.001respectivelybetweenA/
J and C3H animals. { and {{ indicate significant differences compared to PBS-treated animals, p,0.05 and p,0.001 respectively.
doi:10.1371/journal.pone.0003879.g001
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mDCs accompanies AHR development (Figure 2d). However, the
HDM
+ mDC:HDM
+ pDC ratio was significantly elevated in the
lungs of A/J mice (4164 at 72 hours), compared to C3H mice
(1261 at 72 hours). Collectively, this data suggests that develop-
ment of airway responses is associated with a markedly increased
frequency of allergen bearing pulmonary mDCs and a concom-
itantly decreased frequency of allergen-bearing pulmonary pDCs.
As pulmonary DCs have also been demonstrated to play an
important role in promoting asthma exacerbations in previously
sensitized animals [47], we also wished to determine if the balance of
allergen-presenting DCs was similarly skewed towards mDCs in
genetically susceptible mice that had been previously sensitized.
Mice sacrificed 24 and 72 hours after a second allergen exposure to
AF405-HDM displayed a similar bias in allergen uptake by
pulmonary DC subsets – in A/J mice, allergen uptake by mDCs
predominated,while pDCs from resistantC3H micewere frequently
allergen positive (Figure S2). Thus, in susceptible mice, allergen
uptake is principally by immunogenicmDCs, while inresistant mice,
the balance of allergen uptake is shifted towards pDCs.
Co-stimulatory molecule expression on pulmonary DC
subsets
As expression of molecules involved in antigen presentation and
T cell co-stimulation are required for activation of naı ¨ve T cells,
we also compared the expression of MHC Class II and CD86 on
HDM
+ pulmonary mDCs from susceptible and resistant mice 24
and 72 hours after sensitization with AF405-HDM. Interestingly,
we observed that a greater frequency of HDM+ mDCs from A/J
mice stained positive for CD86 and MHC Class II at 24 and
72 hours after allergen challenge by flow cytometry, compared to
those from C3H mice (Fig 3a & c). Moreover, HDM exposure also
increased the number of CD86 and MHC Class II molecules (as
indicated by MFI) on the surface of mDCs from A/J mice
compared to those from C3H mice (Table 1). Similar results were
observed with CD80, OX40L and ICOS-L (data not shown).
Examining co-stimulatory molecule expression on pDCs revealed
that the proportion of HDM
+ pDCs expressing CD86 or MHC
Class II was consistently lower (,2 fold) in susceptible A/J mice
compared to C3H mice, (Figures 3b & 3d). Moreover, HDM
exposure induced significantly higher levels of MHC Class II on
Figure 2. Susceptibility to allergen-induced AHR is associated with increased allergen uptake by pulmonary mDCs. Mice were
sensitized with PBS or AF405-HDM as described in Materials and Methods. AF405 staining of gated mDCs (left panels) and pDCs (right panels) from
naı ¨ve mice (solid black histograms) and mice 24 hours (light grey histograms) or 72 hours (dark grey histograms) after allergen exposure was
determined by flow cytometry (A). Proportion of total mDCs (left panels) and pDCs (right panels) containing allergen in A/J (solid bars) and C3H (open
bars) mice (B) and allergen content (C) was determined by flow cytometry. Ratio of HDM+ mDCs to HDM+ pDCs was calculated (D). Mean+SEM
shown (n=groups of 8 mice in 2 independent experiments). * and ** indicate significant differences of p,0.05 and p,0.001 respectively between A/
J and C3H animals. {{ indicates significant differences compared to PBS-treated animals, p,0.001.
doi:10.1371/journal.pone.0003879.g002
Figure 3. Significantly enhanced co-stimulatory molecule expression on HDM-bearing mDCs from A/J mice. A/J (solid bars) and C3H
(open bars) mice were treated with PBS or AF405-labeled HDM as described in Materials and Methods. Mice were sacrificed 24 and 72 hours after the
second HDM/PBS exposure and lungs were removed. Proportion of HDM
+ mDCs (A) or pDCs (B) expressing MHC Class II, and the proportion of HDM
+
mDCs (C) or pDCs (D) expression CD86, was determined by flow cytometry. Mean+SEM shown. n=8 mice from 2 experiments. * indicates significant
differences of p,0.05 between A/J and C3H animals. {{ indicate significant differences of p,0.001 compared to PBS-treated animals.
doi:10.1371/journal.pone.0003879.g003
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+ pDCs from C3H mice than those from A/J mice (Table 1).
Interestingly, pDCs generally expressed lower levels of MHC Class
II than mDCs from the same mouse (Table 1), supporting previous
reports suggesting that, compared to mDCs, pDCs have limited T
cell stimulatory activity. Collectively, these data demonstrate that
the development of AHR in genetically susceptible animals is
associated with enhanced activation and function of pulmonary
mDCs following allergen sensitization. In contrast, in resistant
animals, there is a shift towards increased activation and allergen
uptake by pulmonary pDCs.
Differences in allergen uptake are not due to differential
DC subset recruitment
Todetermineifincreased allergenuptakeandactivation of mDCs
(A/J mice) or pDCs (C3H mice) observed following intratracheal
sensitization resulted from a greater overall recruitment of the
dominant DC subset to the lung, we examined the number of total
mDCs and pDCs in the lungs of A/J and C3H mice at 24 and
72 hours after HDM sensitization. As shown in Figure 4a, HDM
exposure significantly increased mDC recruitment to the lungs of A/
J and C3H mice (compare to Figure S1). However, at both 24 and
72 hours after HDM exposure, the proportion (Figure 4b), and
number (Figure 4d) of lung cells classified as mDCs was significantly
greater in C3H mice compared to similarly treated A/J mice. In
contrast, HDM exposure had little impact on pDC recruitment in
either strain and pDCs comprised a similar percentage of total lung
cells in both A/J and C3H mice (Figure 4c). While HDM exposure
had little impact on absolute pDC number at 24 hours after allergen
exposure, it tended to increase the number of pDCs present in the
lung after 72 hours, although this did not reach statistical
significance (Figure 4e). Thus, while mDCs are strongly recruited
to the lungs following allergen exposure, they are present, overall, in
lower numbers in A/J mice compared to C3H mice, suggesting that
the comparatively increased allergen uptake observed by A/J mDCs
isnotsimplyareflectionofmoremDCsavailableforallergenuptake.
Similarly skewed allergen uptake by DC subsets is
observed in lung-draining LNs
As initial T cell activation occurs in the lung-draining LN after
allergen sensitization, we compared the distribution of allergen in
DC subsets in the lung-draining LNs of HDM-AF405 sensitized
A/J and C3H mice. We find that recruitment of HDM
+ DC
subsets to the LN peaked at 24 hours, remaining slightly elevated
at 72 hours in both strains (Figure 5a). In contrast, the AF405-
HDM MFI in mDCs and pDCs continued to rise, peaking at
72 hours in both strains (Figure 5b). Comparison of allergen
uptake in DC subsets revealed that compared to C3H mice, more
mDCs from A/J mice contained allergen, while in C3H mice, a
significantly greater proportion of pDCs contained allergen
(Figure 5a). In comparing AF405-HDM MFI, we observed that,
compared to those from resistant mice, mDCs from susceptible
animals contained more allergen at all time points, while pDCs
from resistant mice contained significantly greater levels of
allergen than those from A/J animals (Figure 5b). Thus,
endogenous DC subsets in the lungs and the lung-draining LNs
display similar biases in allergen uptake, suggesting that the
selective accumulation of either HDM
+ mDCs in susceptible mice,
or HDM
+ pDCs in resistant mice may promote the development
of a pathogenic or regulatory T cell response, respectively.
In vivo HDM exposure reduces Th17-associated cytokine
production in resistant mice
As the nature of cytokines produced by DCs directs T cell
differentiation, we also compared pulmonary mDC and pDC
expression of the T cell skewing cytokines IL-6, TNFa, TGFb1,
and p40, a component of both IL-12 (when paired with p35) and
IL-23 (when paired with p19) in DCs from both strains of mice.
We harvested total RNA from flow-sorted, pulmonary mDCs and
pDCs from naı ¨ve, and HDM-exposed A/J and C3H mice
48 hours following a single allergen exposure for real time RT-
PCR analysis of cytokine expression. As shown in Figure 6, mDCs
from naı ¨ve lungs of both strains contained high, but comparable,
levels of message for TNFa, TGFb1, and IL-6, and slightly lower
(but similar) levels of mRNA for p19 and p40 (Figure 6). In
contrast, mDCs from both strains contained very little message for
p35 (Figure 6), resulting in a high p19:p35 ratio, suggesting that
pulmonary mDCs may be biased towards IL-23 production,
potentially supporting the expansion of Th17 cells. Interestingly,
the impact of HDM exposure on mDC cytokine mRNA levels was
different in the two strains. In C3H mice, HDM reduced
pulmonary mDC cytokine production – IL-6, p19, TNFa, and
TGFb1 mRNA were significantly decreased in mDCs from HDM-
Table 1. Co-stimulatory molecule expression on HDM pulmonary DC populations following allergen exposure of A/J and C3H
mice.
Treatment CD86 MFI mDC MHC MFI mDC
A/J C3H A/J C3H
PBS Treated 2,2156496 1,528637 6,06662,066 7,19262,537
HDM - 24 Hours 3,3156360 * 2,325692 27,74863,947 * 16,0706713
HDM - 72 Hours 2,4736170 * 1,9676110 6,7976806 6,7606557
Treatment CD86 MFI pDC MHC MFI pDC
A/J C3H A/J C3H
PBS Treated 1,69961,698 1,54561,500 6,23661,807 6,42061,993
HDM - 24 Hours 3,3686145 4,0426680 7,4186843 * 11,8776991
HDM - 72 Hours 3,0066107 2,8546101 6,2736474 5,340686
a - mDC defined as CD11c
+, CD11b
+,G r 1
2
b - pDC defined as CD11c
+, CD11b
2,G r 1
+
*- indicates significant differences of p,0.05 between strains
doi:10.1371/journal.pone.0003879.t001
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contrast, levels of cytokine message were significantly increased
(TNFa, p40), or present at comparable levels (p19, IL-6) in mDCs
from HDM-sensitized A/J mice compared to mDCs from naı ¨ve
A/J mice (Figure 6). Together, these results suggest that the
response of pulmonary mDCs to inhaled allergen differs in
resistant and susceptible hosts. Moreover, as HDM exposure
reduces p19, IL-6 and TNFa production in resistant, but not
susceptible mice, this may explain the limited production of IL-
17A observed in resistant animals (Figure 1).
As it is still unclear how pDCs promote protective responses to
inhaled allergen, we also examined the impact of HDM on the
expression of cytokines by pulmonary pDCs. Comparing the
cytokine profile of mDCs and pDCs, we found that both subsets
make a similar pattern of cytokines, although pDCs expressed
them at lower levels (Figure S3). One notable difference between
Figure 4. DCs or both subsets are more numerous in the lungs of resistant animals. A/J (solid bars) and C3H (open bars) mice were
sensitized with PBS or HDM as described in Materials and Methods. Mice were sacrificed 24 and 72 hours after the second HDM/PBS exposure and
lungs were removed. mDCs and pDCs were identified by flow cytometry (A). The frequency (B) and absolute (C) number of mDCs and the frequency
(D) and absolute numbers (E) of pDCs in the lungs of PBS- or HDM-treated animals was determined. Mean+SEM shown. n=8 mice from 2
independent experiments. * or ** indicates significant differences of p,0.05 or p,0.001 respectively between A/J and C3H animals. {{ indicates a
significant difference of p,0.001 compared to PBS-treated animals.
doi:10.1371/journal.pone.0003879.g004
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elevated in mDCs, p19 and p35 were expressed at similar levels in
pulmonary pDCs, suggesting that pDCs may produce more IL-12
than mDCs (Figure S3). Comparison of cytokine message in naı ¨ve
pDCs from A/J and C3H mice revealed comparable levels of IL-6,
TNFa, TGFb1. While levels of p40 and p19 tended to be lower in
pDCs from naı ¨ve C3H mice compared to those from A/J mice,
this did not reach statistical significance (Figure S3). Following
HDM exposure however, pDCs from A/J mice were stimulated to
express higher levels of message for IL-6 and TNFa (Figure S3),
but cytokine production by C3H pDCs was unaffected by HDM
exposure. Collectively, these data suggest that aeroallergen-
stimulated cytokine production by pulmonary mDCs and pDCs
differs in genetically resistant and susceptible animals - HDM
exposure does not significantly inhibit cytokine production by
pulmonary DCs in susceptible animals, while such exposure
decreases DC cytokine production in resistant animals.
Similar HDM uptake and co-stimulatory molecule
expression on bone marrow-derived mDCs from A/J and
C3H mice
To determine if the differing responses of endogenous A/J and
C3H mDCs to HDM was a result of an intrinsic difference in
mDC function, or the environment in which the DCs matured (i.e.
the allergen-exposed lung), we exposed bone marrow-derived
dendritic cells (BMDCs) from these two strains to HDM in vitro.
Bone marrow cells cultured with GM-CSF and IL-4 for 6 days
[conditions that induce the development of mDCs [48]] were
pulsed with PBS or AF405-HDM for 24 hours, matured overnight
with LPS, and co-stimulatory molecule expression, antigen uptake
and cytokine expression were assayed. Compared to LPS-matured
BMDCs from A/J mice, those from C3H mice expressed slightly
less MHC Class II and CD86 and substantially less CD80
(Figure 7a), likely the result of impaired LPS-induced maturation
resulting from the lack of functional TLR4 in C3H mice [49].
Surprisingly, in contrast to the limited impact of HDM exposure
on co-stimulatory molecule expression by C3H mDCs in vivo, in
vitro HDM-pulsed, LPS-matured C3H BMDCs displayed similar
(or slightly elevated) induction of co-stimulatory molecule
expression, compared to similarly treated BMDCs from A/J
animals (Figure 7a) suggesting that differences in HDM-induced
mDC maturation between strains is not due to differential
responsiveness to LPS. Moreover, in contrast to the low levels of
allergen captured by C3H mDCs following in vivo AF405-HDM
exposure, when BMDC allergen uptake was compared, a similar
capacity for allergen uptake was observed in BMDCs from A/J
and C3H mice (Figure 7b). Interestingly, in contrast to the
inhibitory impact of in vivo HDM exposure on production of IL-6,
TNFa and p19 by mDCs from C3H mice, mDCs from C3H mice
cultured with HDM in vitro up-regulate the expression of these
cytokines (Figure 7c). Strikingly, this pattern of HDM-induced
cytokine production is similar to that observed in mDCs from the
lungs of sensitized A/J animals (Figure 6), suggesting that over-
expression of these cytokines by pulmonary mDCs may be an
important susceptibility mediator in A/J mice. While LPS-
Figure 5. Susceptibility to allergen-induced AHR is associated with increased allergen uptake by lung-draining LN mDCs. A/J (solid
bars) and C3H (open bars) mice were treated with PBS or AF405-labeled HDM as described in Materials and Methods. Mice were sacrificed 24 and
72 hours after the second HDM/PBS exposure and lung-draining LNs were removed. (A) Frequency of HDM+ mDCs, and (B) mean AF405 intensity was
determined in gated mDCs (left panels) and pDCs (right panels) from A/J and C3H mice. Mean+SEM shown (n=8 mice from 2 independent
experiments). * and ** indicate significant differences between A/J and C3H animals (p,0.05 and p,0.001 respectively). { and {{ indicate significant
differences compared to PBS-treated animals, p,0.05 and p,0.001.
doi:10.1371/journal.pone.0003879.g005
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of cytokine mRNA than those from C3H mice (likely due to the
LPS-unresponsiveness of BMDCs from C3H mice), pulsing A/J
BMDCs with HDM induced a pattern of cytokine expression
associated with promoting/maintaining Th17 responses (elevated
IL-6, TGF-b, IL-23 p19 and comparatively less IL-12 p35) (Figure
S4). Moreover, the levels of cytokine expression induced following
HDM exposure of BMDCs from A/J mice was comparable to the
levels observed in similarly treated BMDCs from resistant C3H
mice (Figure S4). Collectively, these results suggest that during
maturation in the lung, mDCs from resistant mice are exposed to
factors that limit allergen uptake, co-stimulatory molecule
expression and cytokine synthesis normally observed following in
vivo HDM exposure.
Figure 6. HDM exposure increases cytokine expression in pulmonary mDCs from susceptible, but not resistant mice. A/J and C3H
mice were sensitized with a single dose of HDM as described in Materials and Methods. Mice were sacrificed before allergen challenge, or 48 hours
after a single allergen exposure challenge, pulmonary mDCs were isolated by FACS sorting, and total RNA was isolated. Expression of IL-6, IL-23 p19,
TNFa, IL-12/23 p40, TGFb1 and IL-12 p35 were determined by real time PCR. Representative data from 1 of 3 experiments shown. * and ** indicate
significant differences between A/J and C3H mice, p,0.05 and p,0.001 respectively . { indicates significant differences compared to naı ¨ve mice,
p,0.05.
doi:10.1371/journal.pone.0003879.g006
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PLoS ONE | www.plosone.org 9 December 2008 | Volume 3 | Issue 12 | e3879Figure 7. In vitro allergen exposure of BMDCs from resistant mice increases cytokine production and co-stimulatory molecule
expression. mDCs were derived by culturing bone marrow cells in the presence of GM-CSF and IL-4 for 6 days. On day 7, BMDC were pulsed with
30 mg/ml of HDM or medium. On day 8, BMDCs were matured by the addition of 1 mg/ml LPS. (A) After overnight culture, expression of the co-
stimulatory molecules MHC, CD80 and CD86 on LPS (light grey histograms) or LPS+HDM (open histograms) pulsed BMDCs was determined by flow
cytometry. Isotype staining is indicated by dark grey histogram. (B) BMDC from A/J (light grey histogram) or C3H (open histogram) mice were
cultured with HDM-AF405 for 48 hours, and allergen uptake was assessed by flow cytometry. Cells pulsed with unlabelled HDM shown (solid black
histogram). Representative plots from 1 of 2 experiments shown. (C) Cytokine expression by bone marrow-derived mDCs used to sensitize mice was
determined by real time PCR analysis, Mean+SEM shown (n=8 BMDC samples from 2 independent experiments). { indicates significant differences
compared to PBS-pulsed DCs, p,0.05.
doi:10.1371/journal.pone.0003879.g007
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genetically resistant mice susceptible to the
development of AHR
To determine if shifting the phenotype of mDCs involved in
allergen presentation in resistant mice towards one of robust
allergen uptake, high-level co-stimulatory molecule expression,
and production of Th17-associated cytokines is sufficient to cause
AHR in genetically resistant animals, we adoptively transferred
1610
6 in vitro PBS- or HDM-pulsed C3H BMDCs to the airways
of C3H mice on day 0, and challenged with PBS or HDM on day
14. Mice were sacrificed on day 17 to assess airway function, and
pulmonary T cell cytokine expression. In C3H mice sensitized
with PBS-pulsed dendritic cells, subsequent challenge with PBS or
HDM, resulted in levels of AHR (Figure 8a), airway eosinophilia
(Figure 8b), and HDM-restimulated Th2 cytokine production
(Figure 8c) comparable to that seen in PBS-sensitized and
challenged animals (compare to Figure 1a). In contrast, adoptive
transfer of HDM-pulsed BMDCs induced robust AHR (Figure 8a),
and airway eosinophilia (Figure 8b). Strikingly, the level of AHR
induced in resistant C3H mice following sensitization with HDM-
pulsed BMDCs was indistinguishable from that seen in HDM-
exposed A/J mice (compare to Figure 1a). Lung cells from HDM-
pulsed BMDC-sensitized C3H mice produced both Th2 (IL-4, IL-
5, IL-13) and Th1 (IFNc) cytokines (Figure 8c), similar to the
pattern observed following sensitization with HDM, albeit ,10-
fold more intense (compare to Figure 1d). Interestingly, upon
HDM-restimulation, lung cells from these BMDC-sensitized C3H
mice produced levels of IL-17A 100-fold greater than those
observed following intratracheal administration of HDM alone
(Figure 8c). The concomitant induction of a Th17 response,
similar to that observed in A/J mice treated with intratracheal
HDM, is likely the result of elevated p19 and IL-6 production
observed in adoptively transferred DCs (Figure 7c). Collectively,
these results demonstrate that genetic resistance to allergen-
induced AHR can be overcome by limiting the ability of pDCs to
capture antigen and shifting the balance of antigen presentation
towards highly activated, mDCs producing abundant Th17-
skewing cytokines. Furthermore, these data also suggest that the
pulmonary environment in which allergen encounter first takes
place is of critical importance in directing the development of
Figure 8. Adoptive transfer of mDCs to resistant mice induces AHR and IL-17 production similar to that seen in susceptible animals.
C3H mice were sensitized with PBS-, or HDM-pulsed bone marrow-derived DCs on day 0. Mice were challenged with HDM or PBS on day 14 and
sacrificed 72 hours later. AHR (A) and BAL cell composition (B) were examined at sacrifice. Lung cells were also stimulated with HDM in vitro, and
cytokine production was assayed by ELISA (C). { and {{ indicate significant differences (p,0.05 and p,0.001 respectively) compared to PBS-treated
animals or PBS-pulsed DCs.
doi:10.1371/journal.pone.0003879.g008
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Discussion
Previous studies examining the roles of DC subsets in controlling
allergic airway responses demonstrated a pro-asthmatic role for in
vitro-derived mDCs, and a protective role for in vitro-derived pDCs
[27,29,43,50], yet were unable to determine how natural variations
in endogenous DC subset activity influence the development of
pathologic or protective T cell responses, what subset-specific factors
control the development of these T cell responses in vivo,o rw h a t
regulates production of these factors. Herein, we address these
questions, demonstrating that while both mDCs and pDCs take up
allergen in susceptible A/J mice, susceptibility to AHR is associated
with preferential allergen uptake and increased co-stimulatory
molecule expression by pulmonary mDCs. In contrast, in genetically
resistant hosts, a greater frequency of pulmonary pDCs capture, and
are activated by inhaled HDM. In addition, our studies provide
several lines of evidence suggesting that susceptibility to allergen-
induced AHR is associated with the capacity of mDCs to produce
Th17-driving cytokines. First, pulmonary mDCs from genetically
susceptible, allergen challenged mice produce high levelsof IL-6 and
IL-23, cytokines known to drive Th17 responses [14,15,51].
Secondly, in contrast to the limited IL-6 and IL-23 production by
pulmonary mDCs from in vivo allergen-challenged C3H mice,
BMDCs from C3H mice exposed to allergen in vitro produce high
levels of IL-6 and IL-23, and adoptive transfer of these BMDCs
induces the development of AHR indistinguishable from that seen in
genetically susceptible mice. Collectively, our results suggest that in
genetically susceptible animals, the pulmonary environment pro-
motes allergen uptake and production of Th17-skewing cytokines by
pulmonary mDCs that, in turn, promotes the development of
pathologic T cell responses central to disease pathology.
Classically, Th2 cytokines are thought to be the principal
effector molecules driving the development of experimental
asthma [44,52]. Surprisingly, our results suggest that susceptibility
to allergen-driven AHR is associated with a mixed Th2/Th17
cytokine profile in the lung as both susceptible and resistant mice
produced equivalent Th2 cytokines, but only susceptible mice
produced IL-17A following HDM exposure. Furthermore, while
similar patterns of Th1 and Th2 cytokine production were
observed in C3H mice undergoing weak or robust airway
responses, robust airway responses induced by adoptive transfer
of HDM-pulsed BMDCs in normally resistant C3H mice were
accompanied by a dramatic upregulation of IL-17A synthesis. The
involvement of a mixed Th2/Th17 cytokine profile in asthma
pathogenesis is supported by human studies showing increased
production of IL-17A and infiltration of Th17 cells in the lungs of
asthmatics, particularly those with more severe disease [53–56].
Although little is known about the specific role IL-17 plays in
asthma, a recent report demonstrated that IL-17R-/- mice
displayed reduced IgE production, airway eosinophilia and Th2
cytokine production, suggesting that IL-17A was required for
allergic sensitization [57]. However, in the same study, neutral-
ization of IL-17A during the effector phase enhanced AHR,
suggesting a protective role in later stages of disease [57]. As we
observe decreased production of Th17-skewing cytokines during
the initiation of the response in genetically resistant animals, we
speculate that Th17 cells play a pathogenic role in our model.
The observation of a mixed Th2/Th17 response in susceptible
mice is in contrast to our previous observation of a clearly Th2-
dominant pattern of cytokines in susceptible A/J mice and a
preponderance of IFNc in C3H mice in an OVA-based model
[58]. Moreover, OVA-induced AHR in A/J mice was dependent
upon IL-13 [44], and inhibited by IL-12 treatment [59], whereas
in C3H mice, resistance was ablated by blockade of endogenous
IL-12 [60], suggesting that the ability of natural allergens to
efficiently induce pathogenic T cell responses may relate to their
capacity to drive a mixed Th2/Th17 cytokine profile. The specific
components of HDM that enhance its allergenicity remain
unknown. However, while OVA is a single protein, HDM
represents a complex mixture of components – both protein and
non-protein. Two of these proteins, Der p1 and Der p2, possess
potent proteolytic activity [61,62], with the capacity to activate
PAR-2 [63], and regulate of IgE production by cleaving the low
affinity IgE receptor [64]. All of these biologic activities may
potentially contribute to the allergenicity of this mixture. Another
significant component of the HDM extract used in these studies is
contaminating LPS. While low levels of LPS enhance the
development of Th2 responses in the lung [65], and LPS
responsiveness is limited in C3H/HeJ mice used in this study,
we do not think that the failure of the C3H mice to respond to LPS
is responsible for their lack of AHR in our model. While C3H
mice are LPS-resistant, in vitro exposure to HDM+LPS induces
similar levels of co-stimulatory molecule expression and allergen
uptake in BMDCs from A/J and C3H mice. Moreover, we find
that C3H/HeN mice, which possess a functional TLR4, respond
to HDM identically to C3H/HeJ mice. Taken together these
results suggest that any defects in allergen uptake or co-stimulatory
molecule induction resulting from LPS unresponsiveness are
overcome in the presence of HDM.
Interestingly,whilein vivo HDM exposure inhibits allergenuptake,
activation, and production of Th17-skewing cytokines by pulmonary
mDCs from C3H mice, these parameters are maintained, or
enhanced following exposure of bone marrow derived mDCs from
resistant mice to HDM in vitro. Moreover, while pulmonary mDCs
from resistant mice fail to induce AHR, transfer of bone marrow-
derived mDCs pulsed with HDM in vitro induces robust AHR,
demonstrating that DCs from different compartments possess
different functional characteristics. This is wholly compatible with
previous reports demonstrating that the type of signals the DC
receive during maturation, and the tissues from which they are
derived strongly influences their function [32,33,66]. Although the
precise signals provided by the lung environment in C3H mice that
limit pulmonary mDC activation are unclear, there are several
possibilities. First, it is possible that some factor(s) differentially
produced in the lungs of resistant and susceptible animals regulate
the abilityofpulmonarymDCstorespond toHDM.Interestingly,in
the data reported here, pro-asthmatic BMDCs from C3H mice were
differentiated in the presence of GM-CSF. Supporting a role for
GM-CSF in enhancing the pro-asthmatic capacity of DCs, this
cytokine selectively promotes the expansion of myeloid DCs in vivo
[67], increases theexpression of MHC Class II andCD86onDCs in
a murinemodel ofasthma[24],andenhances the capacityofDCsto
support Th2 differentiation in both mice [27,67] and humans [68].
Interestingly,GM-CSFalso enhancesthe production ofIL-6andIL-
23 from DCs [69], leading us to hypothesize that the reduced
capacity for co-stimulatory molecule expression and Th17-skewing
cytokine production observed in C3H pulmonary mDCs may be the
result of limited production of, or responsiveness to, GM-CSF in vivo.
Studies are currently underway to test this hypothesis.
Our observation that shifting the balance of antigen presenta-
tion from activated pulmonary pDCs to activated mDCs is
sufficient to induce airway responses in genetically resistant hosts
also suggests that the presence of activated pDCs may limit the
pro-asthmatic capacity of pulmonary mDCs. Such pDC-mediated
inhibition of AHR may occur in a number of ways. We have
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significantly inhibit mDC-mediated T cell activation, suggesting
that pDCs can directly limit mDC activity [70]. Additionally,
while our ex vivo analysis of cytokine production by pulmonary
pDCs did not reveal striking differences in cytokine production in
pDCs between strains, it suggested that pDCs may be a source of
IL-12, a cytokine that prevents allergen-induced AHR in this
model [60]. Alternatively, as pDCs have been shown to be potent
inducers of regulatory T cells [29–31], the increased activation of
pulmonary pDCs observed in allergen-challenged resistant mice
may contribute to a regulatory response responsible for controlling
AHR. Consistent with this possibility, we previously demonstrated
that in vivo Treg depletion in C3H mice significantly increased
pulmonary mDC activity and AHR, while having no impact on
these parameters in A/J mice [71]. Thus, through a variety of
mechanisms, activated pDCs in the lungs of resistant animals may
play a role in suppressing pulmonary mDC activation, and
development of AHR.
The genetic factors underlying differential recruitment, capacity
for allergen uptake, and Th17-driving cytokine production by
pulmonary mDCs in susceptible and resistant mice remain
unclear. However, we have previously identified two regions on
murine chromosome 2 (Abhr1 and Abhr2) that are strongly linked
with asthma susceptibility in this model [58]. While mDCs from
allergen-challenged A/J mice demonstrated enhanced capacity for
allergen uptake (compared to those from C3H mice), fewer mDCs
were present in the lungs of A/J animals, suggesting that genetic
differences associated with susceptibility to allergen-induced AHR
govern the function of distinct DC subsets, and not their selective
recruitment. Close examination of the factors differentially
expressed by pulmonary mDCs from A/J and C3H mice (IL-6,
either IL-23 subunit, TNFa, co-stimulatory molecules) reveals that
none are located within the genomic regions associated with
susceptibility. However, C5a [absent in A/J mice due to a
naturally occurring 2-base pair deletion [72]], located within Abhr1
and strongly associated with the development of allergic asthma
[73], has been shown to regulate IL-23 production [74] and the
pulmonary mDC:pDC ratio [70]. Thus, in the lungs of resistant
mice, production of complement components, likely by the
epithelium, may negatively regulate mDC phagocytic capacity,
activation, and production of Th17-driving cytokines, such that
upon allergen exposure, the actions of pDCs predominate, and
allow the development of an appropriate regulatory response.
Thus, our studies provide new insights into the phenotype of
endogenous DCs that drive airway hyperresponsiveness. We
demonstrate that genetic susceptibility to the development of
allergen-induced AHR is the result of a pulmonary environment
which, following allergen exposure, allows allergen presentation by
mDCs expressing high levels of co-stimulatory molecules, and
producing a Th17-promoting cytokine profile (IL-23 and IL-6). On
the other hand, factors present in the lungs of resistant mice shift the
balance of allergen uptake and activation from immunogenic mDCs
to tolerogenic pDCs. Identification of the exact lung factors that
preferentially regulate myeloid DC activation and promote the
subsequent development of Th2/Th17 responses to harmless
inhaled antigens should inform the development of improved
therapies for the treatment of this ever increasing disease.
Materials and Methods
Mice
Male A/J and C3H/HeJ mice (5–6 weeks old, Jackson
Laboratories, Bar Harbor, ME) were housed in a specific
pathogen-free facility at Cincinnati Children’s Hospital (Cincin-
nati, OH). Cincinnati Children’s Hospital IACUC approved all
animal protocols.
Treatment protocols
MiceweretreatedwithHDMextract(100 mg; GreerLaboratories,
Lenoir, NC) or 40 ml PBS (Invitrogen, Carlsbad, CA) intratracheally
(i.t.) on days 0 and 14. LPS content of the HDM extract was reported
by the manufacturer to range between 0.043–0.047 EU/mgo f
protein. Mice weresacrificed 24 or72 hoursafterHDMexposure for
assessment of airway function and DC recruitment. Where indicated,
AlexaFluor405 (Invitrogen, Carlsbad, CA) labeled HDM (AF405-
HDM) was used. Alternatively, mice were sensitized with 2610
6
HDM-pulsed, bone marrow-derived mDCs.
Development of mature, HDM-pulsed bone marrow
derived myeloid DCs
Bone marrow cells (3610
5 cells/ml) were cultured in complete
RPMI supplemented with GM-CSF (10 ng/ml, Peprotech, Rocky
Hill, NJ, USA) and IL-4 (10 ng/ml, Peprotech). Medium was
changed on day 3. On day 6, cells were cultured with HDM or
AF405-HDM (30 mg/ml) and GM-CSF (10 ng/ml) for 24 hours.
LPS was added at a final concentration of 1 mg/ml. 12 hours later
the DCs were harvested, washed extensively in PBS and used for
subsequent studies. BMDCs were consistently ,95% mDCs, and
expressed high levels of MHC Class II, CD80 and CD86.
Assessment of allergen induced allergic responses
To evaluate airway responses, mice were anaesthetized, intubated
and respirated at a rate of 120 breaths per minute with a constant
tidal volume (0.2 ml) and paralyzed with decamethonium bromide
(25 mg/kg) 72 hours after final allergen challenge. Acetylcholine
(50 mg/kg) was injected into the inferior vena cava and dynamic
airway pressure (cm H20 x sec) was followed for 5 minutes.
Immediately after AHR measurements, blood was collected to test
for total and HDM specific IgE using Abs from Pharmingen (San
Diego, CA). To collect BALF, lungs were lavaged three times with a
1.0-ml aliquot of cold Hanks’ balanced salt solution (Invitrogen,
Carlsbad, CA). Recovered lavage fluid (70 to 80%) was centrifuged
(300g for 8 min) and thecellpellet resuspended in1.0 mlof 10% FBS
in PBS. Total cells were counted with a hemocytometer. Slides were
prepared by cytocentrifugation (Cytospin 3; Shandon Instruments,
Pittsburgh, PA), and stained with Diff-Quik (Dade Behring,
Du ¨dingen, Switzerland). Bronchoalveolar lavage (BAL) cell differ-
ential counts were determined using morphologic criteria under a
light microscope with evaluation of $ 500 cells/slide.
Lung and LN cell isolation
After AHR measurements, LNs and lungs were removed,
minced and placed in 6 ml of RPMI 1640 containing Liberase CI
(0.5 mg/ml)(Roche Diagnostics, Indianapolis, IN) and DNase I
(0.5 mg/ml)(Sigma, St. Louis, MO) at 37uC for 45 minutes. The
tissue was forced through a 70-micron cell strainer, and red blood
cells were lysed with ACK lysis buffer (Invitrogen). Cells were
washed with RPMI containing 10% FBS, viable cells were
counted via trypan blue exclusion. Where indicated lung cells were
cultured at 350,000 cells per well in a 96 well plate (250 ml final
volume) with HDM (30 mg/ml). Tissue culture supernatants were
harvested at 72 hours.
Flow Cytometry
Staining reactions were performed at 4uC following incubation
with FcBlock (mAb 2.4G2) for 30 minutes. Myeloid DCs
(CD11c
+, CD11b
+, Gr1
2) and plasmacytoid DCs (CD11c
+,
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2, Gr1
+) were quantified using anti-CD11c-APC (HL3),
anti-CD11b-PE-Cy7 (M1/70), and anti-Gr1-APC-Cy7 (RB6-
8C5). Co-stimulatory molecule expression was examined using
PE-conjugated mAbs to MHC Class II (14-4-4s), CD86 (GL1), B7-
H1 (MIH5) and B7-DC (TY25). Dead cells were excluded using 7-
AAD. Data were acquired with an LSRII flow cytometer (BD
Biosciences, San Jose, CA) equipped with lasers tuned to 488nm,
633nm, and 405nm. Cell sorts were performed on a FACSVan-
tage SE flow cytometer (BD Biosciences) equipped with lasers
tuned to 488 nm argon laser, and a 633 nm. Spectral overlap was
compensated using the FACSDiVa software (BD Biosciences) and
analyzed using FlowJo software (Treestar Inc., Ashland, OR).
Determination of Cytokine Concentration
Cytokine levels in samples were measured by ELISA using
matched antibody pairs purchased from Pharmingen (IL-4, IL-5) or
R&D Systems (IL-13, Minneapolis, MN). Tissue culture superna-
tants were frozen at 280uC and thawed immediately prior to use.
Quantitative real-time RT-PCR
To measure IL-12/23 p40, IL-23 p19, IL-6, IL-12 p35, TGFb1
and TNFa message expression in sort-purified pulmonary mDCs
or BMDCs, we used quantitative RT-PCR [75]. PCR primer pairs
for IL-6 and IL-12/23 p40 were designed using Beacon Designer
software, while primer pairs for IL-23/23p19 were obtained from
the mouse primer depot [76]. Primers were: IL-6 sense ACA ACC
ACG GCC TTC CCT AC; IL-6 anti-sense – AGC CTC CGA
CTT GTG AAG TGG; IL-12/23 p40 sense – CAG AAG CTA
ACC ATC TCC TGG; IL-12/23 p40 antisense – AGT CCA
GTC CAC CTC TAC AAC; IL-23 p19 sense – GAC CCA CAA
GGA CTC AAG GA; IL-23 p19 anti-sense – CAT GGG GCT
ATC AGG GAG TA, IL-12 p35 sense – GCT TCT CCC ACA
GGA GGT TT; IL-12 p35 anti-sense – CTA GAC AAG GGC
ATG CTG GT; TNFa sense – CAT CTT CTC AAA ATT CGA
GTG ACA A; TNFa anti-sense – TGG GAG TAG ACA AGG
TAC AAC CC; TGFb1 sense – AAT TCC TGG CGT TAC
CTT GG; TGFb1 anti-sense – GGC TGA TCC CGT TGA
TTT CC. All primers were designed to span an intronic region to
avoid co-amplification of genomic DNA.
Statistical Analysis
To determine differences between multiple groups, analysis of
variance (ANOVA) was used with post hoc comparisons using
Fisher’s method. For comparison between two groups, a Student’s
t-test was performed. Significance was assumed at p,0.05.
Supporting Information
Figure S1 DC subsets found in the lung of mice. A/J mice
treated with PBS were sacrificed, and lung cells stained with 7-
AAD, and antibodies to CD11c, Gr1, and CD11b. 7-AAD- cells
were gated for analysis of CD11b, CD11c, and Gr1 expression. (A)
mDCs (CD11c+, CD11b+, Gr12) and pDCs (CD11c+, CD11b2,
Gr1+) cells can clearly be found in the lungs. Other major
populations identified included neutrophils (CD11c+, CD11b+,
Gr1+) and alveolar macrophages (CD11c+, CD11b2, Gr12). (B)
Gated DC population were analyzed for expression of B220, and
CD317 with independent CD317-specific clones (120g8 and
mPDCA-1).
Found at: doi:10.1371/journal.pone.0003879.s001 (2.49 MB TIF)
Figure S2 Enhanced allergen uptake by pulmonary mDCs in
susceptible mice is observed in previously sensitized animals. A/J
(solid bars) and C3H (open bars) mice were sensitized and
subsequently challenged with PBS or AF405-HDM as described in
Materials and Methods. Proportion of total mDCs (left panels) and
pDCs (right panels) containing allergen (A) and allergen content
(B) was determined by flow cytometry. Mean+SEM shown
(n=groups of 8 mice in 2 independent experiments). * and **
indicate significant differences of p,0.05 and p,0.001 respec-
tively between A/J and C3H animals. {{ indicates significant
differences compared to PBS-treated animals, p,0.001.
Found at: doi:10.1371/journal.pone.0003879.s002 (0.33 MB TIF)
Figure S3 Cytokine expression in pDCs from naı ¨ve and HDM-
treated mice. A/J and C3H mice were sensitized with a single dose
of HDM as described in Materials and Methods. Mice were
sacrificed before allergen challenge, or 48 hours after a single
allergen exposure challenge, pulmonary pDCs were isolated by
FACS sorting, and RNA was isolated. Expression of IL-6, IL-23
p19, TNFa, IL-12/23 p40, TGFb1 and IL-12 p35 were
determined by real time PCR. Representative data from 1 of 3
experiments shown. * indicates significant differences between A/J
and C3H mice, p,0.05
Found at: doi:10.1371/journal.pone.0003879.s003 (0.45 MB TIF)
Figure S4 Cytokine expression by HDM-treated BMDCs from
A/J mice. mDCs were derived by culturing bone marrow cells in
the presence of GM-CSF and IL-4 for 6 days. On day 7, BMDC
were pulsed with 30 mg/ml of HDM or medium. On day 8,
BMDCs were matured by the addition of 1 mg/ml LPS. Cytokine
expression by bone marrow-derived mDCs was determined by
real time PCR analysis. Mean+SEM shown (n=8 BMDC samples
from 2 independent experiments). {{ indicates significant
differences compared to PBS-pulsed DCs, p,0.001.
Found at: doi:10.1371/journal.pone.0003879.s004 (0.20 MB TIF)
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